Outset Medical (OM) Common Equity (2019 - 2026)

Outset Medical (OM) has 8 years of Common Equity data on file, last reported at $111.7 million in Q1 2026.

• On a quarterly basis, Common Equity fell 34.25% year-over-year to $111.7 million in Q1 2026; TTM through Mar 2026 was $111.7 million, a 34.25% decrease from a year earlier, with the FY2025 full-year figure at $127.0 million, up 373.37% from the prior year.
• Common Equity for Q1 2026 stood at $111.7 million, down from $127.0 million in the prior quarter.
• Over the last five years, Common Equity for OM reached as high as $345.5 million in Q1 2022 and fell as low as $26.8 million in Q4 2024.
• Historically, Common Equity has averaged $164.5 million across 5 years, with a median of $152.1 million in 2023.
• Across the five-year window, Common Equity plunged 78.18% in 2024 and surged 373.37% in 2025, its largest moves.
• Year by year, Common Equity stood at $246.0 million in 2022, then tumbled by 50.04% to $122.9 million in 2023, then plunged by 78.18% to $26.8 million in 2024, then jumped by 373.37% to $127.0 million in 2025, then dropped by 12.02% to $111.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $111.7 million in Q1 2026, $127.0 million in Q4 2025, and $142.4 million in Q3 2025.